With increased pressures to run smaller, quicker studies that need to deliver more answers than ever before we are tasked with designing innovative studies that can meet these demands but remain statistically sound. This 1-day meeting aims to address how we, as statisticians, can better communicate the underlying complex statistical methodology such that our clinical colleagues better understand the risks and the decisions they will be able to make at the end of the study.
Registration & Coffee
Welcome & Introduction
Some experiences of communicating probabilities and errors in Exploratory Development at UCB Ros Walley & Peter Colman (UCB)
A picture is worth a thousand words - usually Stephen Senn (CRP-Santé)
Tea & Coffee
A thousand numbers cannot say enough: communicating Bayesian statistics using examples, intuition and common sense Simon Wandel (Novartis)
Prediction as Inference Harry Southworth (Data Clarity Consulting)
Unconventional clinical development trials - what can possibly go wrong? A case study Bill Richardson (NDA Group)
Communicating Benefits and Risks of Medicines for Decision-Making Deborah Ashby (Imperial College London)
Tea & Coffee
Statistician Heal Thyself – Good Communication Requires Real Understanding Andy Grieve (Aptiv Solutions)
Attendance at the course counts as 7.5 hours towards any CPD requirements
Many thanks to UCB for hosting this event
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.